MC
VXRT

Moors & Cabot’s Vaxart VXRT Stock Holding History

Moors & Cabot’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,000
Closed -$13.3K – 916
2024
Q2 		$13.3K Hold
20,000
– – ﹤0.01% 841
2024
Q1 		$26K Hold
20,000
– – ﹤0.01% 883
2023
Q4 		$11.5K Hold
20,000
– – ﹤0.01% 824
2023
Q3 		$15.1K Hold
20,000
– – ﹤0.01% 819
2023
Q2 		$14.6K Hold
20,000
– – ﹤0.01% 814
2023
Q1 		$15.1K Hold
20,000
– – ﹤0.01% 833
2022
Q4 		$19.2K Hold
20,000
– – ﹤0.01% 824
2022
Q3 		$44K Buy
20,000
+10,000
+100% +$34.5K ﹤0.01% 794
2022
Q2 		$35K Hold
10,000
– – ﹤0.01% 780
2022
Q1 		$50K Hold
10,000
– – ﹤0.01% 839
2021
Q4 		$63K Buy
+10,000
New +$68.3K ﹤0.01% 836

Other funds holding VXRT

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Moors & Cabot's VXRT Position: Q3 2024 in Review

Moors & Cabot sold out of Vaxart (VXRT) in Q3 2024, closing a stake of 20,000 shares — an estimated $13.3K sold.

Moors & Cabot first reported a position in VXRT in Q4 2021 and held it in 11 quarters. The position peaked at $63K in Q4 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q3 2024.

  • Moors & Cabot reported no remaining Vaxart position as of Q3 2024 after selling out during the quarter.
  • Moors & Cabot sold 20,000 Vaxart shares in Q3 2024, an estimated $13.3K.
  • Moors & Cabot first reported a position in Vaxart in Q4 2021 and held it in 11 quarters.
  • Moors & Cabot's Vaxart position peaked at $63K in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q3 2024.

Based on Moors & Cabot's 13F filing for Q3 2024, filed 8 Nov 2024.